Knowledge, attitudes, and acceptance toward COVID-19 vaccine of gynecologic cancer patients in Thailand: A Multicenter study
Recruiting
- Conditions
- Covid vaccine acceptance in gynecologic cancer patientscovid-19, gynecologic cancer
- Registration Number
- TCTR20220214006
- Lead Sponsor
- Chiang Mai university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 1200
Inclusion Criteria
Women diagnosed with gynecologic cancer and can understand Thai language.
Exclusion Criteria
received Covid-19 vaccine before diagnosed with gynecologic cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Covid-19 vaccine acceptance At recruitment score (report in mean/median)
- Secondary Outcome Measures
Name Time Method Knowledge about Covid-19 vaccine At recruitment score (report in mean/median)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms influence SARS-CoV-2 vaccine acceptance in gynecologic oncology populations?
How do attitudes toward mRNA vaccines compare with traditional inactivated virus vaccines in cancer patients?
Which biomarkers correlate with immune response variability in gynecologic cancer patients receiving BNT162b2 or mRNA-1273 vaccines?
What adverse event management strategies are effective for gynecologic cancer patients post-COVID-19 vaccination?
How does combination therapy with immune checkpoint inhibitors affect vaccine efficacy in HPV-related gynecologic malignancies?